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Background. The lower respiratory tract infection (LRTI)-associated hospitalization rate in American Indian
and Alaska Native (AI/AN) children aged B5 years declined during 19982008, yet remained 1.6 times
higher than the general US child population in 20062008.
Purpose. Describe the change in LRTI-associated hospitalization rates for AI/AN children and for the general
US child population aged B5 years.
Methods. A retrospective analysis of hospitalizations with discharge ICD-9-CM codes for LRTI for AI/AN
children and for the general US child population B5 years during 20092011 was conducted using Indian
Health Service direct and contract care inpatient data and the Nationwide Inpatient Sample, respectively. We
calculated hospitalization rates and made comparisons to previously published 19981999 rates prior to
pneumococcal conjugate vaccine introduction.
Results. The average annual LRTI-associated hospitalization rate declined from 19981999 to 20092011
in AI/AN (35%, pB0.01) and the general US child population (19%, SE: 4.5%, pB0.01). The 20092011
AI/AN child average annual LRTI-associated hospitalization rate was 20.7 per 1,000, 1.5 times higher than
the US child rate (13.7 95% CI: 12.614.8). The Alaska (38.9) and Southwest regions (27.3) had the highest
rates. The disparity was greatest for infant (B1 year) pneumonia-associated and 20092010 H1N1 influenza-
associated hospitalizations.
Conclusions. Although the LRTI-associated hospitalization rate declined, the 20092011 AI/AN child rate
remained higher than the US child rate, especially in the Alaska and Southwest regions. The residual disparity
is likely multi-factorial and partly related to household crowding, indoor smoke exposure, lack of piped water
and poverty. Implementation of interventions proven to reduce LRTI is needed among AI/AN children.
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L
ower respiratory tract infection (LRTI) is the lead-
ing cause of hospitalization in US children aged
B5 years (1). Pneumonia and bronchiolitis are the
most common causes of LRTI-associated hospitalizations
in US children aged B5 years (2). Among American
Indian and Alaska Native (AI/AN) children, there have
been persistently higher rates of LRTI-associated hospi-
talizations compared to the general US child population
(24). We last examined this disparity for 20062008 and
found that the LRTI-associated hospitalization rate for
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AI/AN children aged B5 years was approximately 1.6
times higher than the corresponding general US child
rate, with greater disparities in AI/AN infants (B1 year)
and in AI/AN children in Alaska and the Southwest
regions (2). Since 2008, the H1N1 outbreak occurred
(20092010) and the 13-valent pneumococcal conjugate
vaccine (PCV13) replaced 7-valent PCV in March 2010
(5). In the present study, we describe the change in LRTI-
associated hospitalization rates in AI/AN children and in
the general US child population aged B5 years between
19981999 and 20092011 to compare rates before and
after the introduction of the PCV vaccine and the H1N1
influenza outbreak.
Methods
This manuscript was reviewed and approved for publica-
tion by the Alaska Native Tribal Health Consortium,
Yukon Kuskokwim (YK) Health Corporation, Maniilaq
Association and Indian Health Service (IHS).
We performed an analysis of 19982011 hospital dis-
charge data with an LRTI-associated diagnosis among
2 populations: AI/AN children aged B5 years who were
hospitalized at an IHS-operated, tribally operated or
contract hospital, and the general US child population
aged B5 years. All hospital discharge records with an
LRTI listed as any one of up to 15 diagnoses were selected
from the respective data sets: (a) the IHS Direct and
Contract Health Service Inpatient Dataset record for AI/
AN children (6,7) and (b) the Nationwide Inpatient
Sample (NIS) for the general US child population (8).
Hospital stays for newborns (births) were excluded, and
the unit of analysis is a hospitalization. The International
Classification of Diseases, Ninth Revision, Clinical Modifi-
cation (ICD-9-CM) (9) codes consistent with LRTI were
previously defined by Peck et al. as any one of the fol-
lowing diagnoses (ICD-9-CM codes in parentheses):
pulmonary tuberculosis (011), pulmonary anthrax (022.1),
pulmonary diseases caused by Mycobacterium (031.0),
whooping cough (033), respiratory syncytial virus (RSV)
(079.6), syphilis of lung (095.1), acute bronchitis (466.0),
acute bronchiolitis (466.1), pneumonia (480486), influ-
enza (487), influenza due to identified 2009 H1N1 influ-
enza virus (488.1), empyema (510), pleurisy with effusion
(511.1), abscess of lung and mediastinum (513), rheu-
matic pneumonia (517.1) and congenital pneumonia
(770.0) (2,3). Acute bronchiolitis, pneumonia, RSV
(466.11, 480.1 and 079.6) and influenza (487 and 488.1)
were further examined. A bronchiolitis-associated hospi-
talization without pneumonia listed as a diagnosis and
percentage of LRTI-associated hospitalizations due to
pneumonia were also analyzed. The data were examined
by time period, age group (infant and 14 years), sex,
IHS region (for AI/ANs), LRTI category (bronchiolitis,
pneumonia, RSV and influenza) and hospital length
of stay.
For AI/AN children aged B5 years, IHS direct and
IHS-contract health service inpatient data were obtained
from the IHS National Patient Information Reporting
System (2,7,10). These data consisted of all hospital dis-
charge records reported directly from IHS- and tribally
operated hospitals and community hospitals that are
contracted with IHS or tribes to provide health care
services to eligible AI/AN people (6). The IHS adminis-
trative areas were classified by region: East (Nashville);
Northern Plains (Aberdeen, Bemidji and Billings); Alaska,
Southern Plains and Southwest (Albuquerque, Navajo,
Phoenix and Tucson). We excluded the IHS California
and Portland (Oregon) Administrative Areas because
neither had any IHS- or tribally operated hospitals (6,11).
The average annual rates per 1,000 AI/AN children
were calculated from corresponding groups using the
IHS user population which includes all registered AI/AN
people who received IHS-funded health care service at
least once during the preceding 3 years (2,6). Influenza-
associated infant hospitalizations were examined for
April 2009 to March 2010 to take into account the influ-
enza season using the corresponding IHS user population
for that period. The Alaska IHS region was further
analyzed for the YK Delta and Maniilaq sub-regions,
which had the highest LRTI-associated average annual
hospitalization rates, for 20012003 and 20092011
(8,12,13).
For the general US child population aged B5 years,
LRTI-associated hospitalizations were examined using
the NIS, a national representative sample of hospitals
conducted by the Healthcare Cost and Utilization Project
(HCUP) (8). Participating hospitals are short-term, non-
federal general and specialty hospitals sampled annually;
these data do not include IHS/tribal facilities’ hospital
discharge data. National estimates of the number of hos-
pitalizations were calculated using the HCUP weighting
methodology for the NIS (8). SUDAAN software was
used to account for the sampling design of the US
nationwide inpatient data and generate standard errors
(SEs) of hospitalization estimates (14). Average annual
hospitalization rates per 1,000 children with 95% con-
fidence intervals (CIs) from 2009 to 2011 were calculated
for corresponding groups with denominators determined
from the National Center for Health Statistics bridged
race population estimates (8,15). Additionally, an annual
infant influenza-associated hospitalization rate per 1,000
infants with a 95% CI from April 2009 to March 2010
was calculated.
Overall, average annual rates for 20092011 were also
compared to corresponding previously published average
annual rates for 19981999 and 20062008 for LRTI,
bronchiolitis, pneumonia and RSV; rate ratios (RRs)
with 95% CIs were calculated using Poisson regression
analysis for IHS data, (16) and relative SEs for ratio esti-
mators were calculated using SUDAAN for NIS data (17).
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The hospital discharge data used for these earlier time
periods were available for the analysis (2,3). The average
annual percent rate of change between 19981999 and
20092011 rates was also calculated. Median length of stay
comparison by period was performed using the Wilcoxon




The average annual LRTI-associated hospitalization rate
for 20092011 in AI/AN children aged B5 years was
20.7 per 1,000, approximately 1.5 times greater than the
general US child population aged B5 years (13.7, 95%
CI: 12.614.8) (Table I and Table II). The average annual
LRTI-associated hospitalization rate declined from 1998
1999 to 20092011 in both AI/AN (35% decline, pB0.01)
and US children (19% decline, SE: 4.5%, pB0.01) (Fig. 2).
The 20092011 LRTI-associated hospitalization rate was
5% less (pB0.01) than the 20062008 rate of 21.8 per
1,000 for AI/AN children, while the rate for US children
was not significantly different than the 20062008 rate
(RR 0.99, 95% CI: 0.881.10). For 20092011, 50% of all
hospitalizations in AI/AN children were LRTI associated
compared to 28% (SE: 0.6%) in the general US child
population.
For 20092011, the median length of stay for LRTI-
associated hospitalizations was 2.0 days (quartiles 1.0, 3.0
days) for AI/AN children and 1.9 days (quartiles 1.1, 3.3
days) for US children. The median length of stay for AI/
AN children decreased from 3.0 days in 19981999
(quartiles 2.0, 4.0, pB0.01), but did not change for US
children (p0.32).
Pneumonia-associated hospitalizations
The 20092011 average annual pneumonia-associated
hospitalization rate for AI/AN children (12.2) was almost
2 times higher than the US child rate (6.7, 95% CI: 6.2
7.2), while the AI/AN infant pneumonia-associated hos-
pitalization rate (36.9) was approximately 3 times higher
than the US infant rate (11.7, 95% CI: 10.812.7) (Fig. 1,
Table I and Table II). The rates declined from 19981999
to 20092011 for AI/AN infants (34%, pB0.01) and
US infants (37%, SE: 3.5%, pB0.01), and continued to
decline during 20092011 (Fig. 2). AI/AN infants had a
greater percentage of LRTI-associated hospitalizations
due to pneumonia than US infants (34 and 20%, SE:
0.5%, respectively).
The 20092011 average annual pneumonia-associated
hospitalization rate for AI/AN infants was highest in
Alaska (67.6 per 1,000), and approximately 6 times higher
than the general US infant rate (Table I). Within Alaska,
the YK Delta sub-region infant hospitalization rate
(117.4) was approximately 10 times higher than the US
rate, but decreased by 49.4% from 2001 to 2003 (232.2,
pB0.01). In contrast, the 20092011 infant hospitaliza-
tion rate in Maniilaq sub-region in Alaska (172.5) was
approximately 15 times higher than the US infant rate,
and increased by 98.3% from 2001 to 2003 (87.0,
pB0.01).
Bronchiolitis-associated hospitalizations
The 20092011 average annual bronchiolitis-associated
hospitalization rate for AI/AN infants was approximately
1.7 times higher than that for US infants [44.6 and 26.1
(95% CI: 23.728.6), respectively] (Table I and Table II).
The rate decreased from 19981999 to 20092011 for
both AI/AN infants (42%, pB0.01) and US infants
(18%, SE: 5.3%, pB0.01) (Fig. 2).
RSV-coded hospitalizations
The 20092011 RSV-coded average annual hospitaliza-
tion rates for AI/AN and US infants were 22.1 and 16.6
(95% CI: 15.118.2), respectively (Table I and Table II).
Over the period spanning 19981999 to 20092011, the
rate of RSV-related hospitalization declined by 36% for
AI/AN infants (pB0.01) and 20% (SE: 5.1%) for US
infants (pB0.01) (Fig. 2). Alaska and the Southwest had
the highest regional AI/AN infant RSV-associated hos-
pitalization rates (43.1 and 25.4, respectively). Alaska
experienced the largest regional infant hospitalization
rate decline (52%, pB0.01) from 19981999 to 2009
2011 among IHS regions.
Influenza-associated hospitalizations
For April 2009March 2010, the 2009 H1N1 influenza
pandemic period, the annual rate of infant influenza-
associated hospitalizations was approximately 3 times
higher for AI/AN infants (9.9) than US infants (3.3, 95%
CI: 2.72.9) and about 12 times higher for AI/AN infants
in Alaska (38.9) (Fig. 2).
Discussion
The average annual rate of LRTI-associated hospitaliza-
tions in AI/AN children and in the general US child
population aged B5 years declined significantly from
19981999 to 20092011. However, there remains a per-
sistent disparity in the rate of LRTI-associated hospita-
lizations between AI/AN children and the general US
child population. The 20092011 AI/AN rate was 1.5
times higher than the general US child population rate,
which was similar to the disparity from 2006 to 2008 (1.6
times higher) but slightly less than the disparity from
1998 to 1999 (1.9 times higher) (2,3). The disparity in
LRTI-associated hospitalization rates in 20092011 was
greatest for AI/AN infants (2.1 times higher than the
general US child population). LRTI-associated hospita-
lizations accounted for about half of all hospitalizations
in AI/AN children compared to about one-quarter of all
hospitalizations for US children. The rate disparity was
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Table I. Average annual rates of lower respiratory tract infection (LRTI)-, bronchiolitis- and pneumonia-hospitalizations among American Indian and Alaska Native children aged B5
years, by age group and sex, 19981999 and 20092011a





















B1 121.5 75.1 0.62 (0.590.64)d 55.7 36.9 0.66 (0.620.71)d 77.3 44.6 0.58 (0.550.61)d
14 15.3 11.3 0.74 (0.700.78)d 11.4 7.9 0.69 (0.660.74)d 4.6 4.2 0.91 (0.830.99)d
Sex by age (year)
Male 34.1 22.2 0.65 (0.620.68)d 19.4 12.9 0.67 (0.630.71)d 17.0 11.0 0.65 (0.610.69)d
B1 133.4 82.6 0.62 (0.580.66)d 60.6 40.3 0.67 (0.610.72)d 84.8 50.3 0.59 (0.550.64)d
14 15.6 11.8 0.76 (0.740.81)d 11.7 8.2 0.70 (0.650.76)d 4.3 4.2 0.97 (0.851.09)
Female 29.7 19.1 0.64 (0.610.67)d 17.2 11.4 0.66 (0.620.70)d 14.9 9.2 0.62 (0.580.66)d
B1 109.0 67.2 0.62 (0.580.66)d 50.6 33.4 0.66 (0.600.72)d 69.3 38.8 0.56 (0.510.61)d
14 15.0 10.8 0.72 (0.670.78)d 11.0 7.6 0.69 (0.630.75)d 4.9 4.1 0.85 (0.760.96)d
Region by age (year)
Alaska 51.8 38.9 0.75 (0.700.81)d 29.5 22.6 0.77 (0.700.84)d 28.6 16.3 0.57 (0.510.63)d
B1 190.4 136.4 0.72 (0.660.78)d 92.6 67.6 0.73 (0.640.83)d 125.1 68.2 0.55 (0.480.61)d
14 21.4 17.0 0.79 (0.700.90)d 15.7 12.5 0.80 (0.690.92)d 7.5 4.6 0.62 (0.500.77)d
East 21.5 10.8 0.50 (0.400.63)d 15.1 6.1 0.41 (0.300.54)d 7.2 4.9 0.68 (0.470.99)d
B1 66.6 33.3 0.50 (0.350.71)d 42.6 11.9 0.28 (0.170.47)d 29.5 22.8 0.77 (0.481.25)
14 14.0 6.9 0.49 (0.360.68)d 10.5 5.1 0.49 (0.340.70)d 3.4 1.8 0.52 (0.280.97)d
Northern Plains East 5.5 3.5 0.63 (0.470.85)d 4.0 2.4 0.60 (0.420.85)d 1.9 1.2 0.66 (0.401.10)
B1 22.5 13.4 0.60 (0.390.91)d 14.4 9.4 0.65 (0.391.09) 10.2 4.9 0.48 (0.250.93)d
14 3.0 2.1 0.72 (0.471.09) 2.4 1.4 0.59 (0.360.96)d 0.6 0.8 1.17 (0.512.69)
Northern Plains West 32.5 19.6 0.60 (0.560.65)d 21.9 13.7 0.63 (0.570.69)d 11.2 7.5 0.67 (0.590.76)d
B1 113.7 72.6 0.64 (0.570.71)d 64.8 44.3 0.68 (0.590.79)d 53.7 37.3 0.69 (0.600.81)d
14 16.9 10.7 0.64 (0.560.72)d 13.6 8.6 0.63 (0.550.72)d 2.9 2.5 0.84 (0.641.09)
Southern Plains 11.9 5.4 0.45 (0.400.52)d 8.2 2.8 0.34 (0.290.40)d 4.9 3.3 0.67 (0.560.80)d
B1 47.1 22.0 0.47 (0.390.55)d 26.9 8.0 0.30 (0.230.39)d 28.3 17.7 0.62 (0.510.76)d
14 6.1 2.9 0.47 (0.390.57)d 5.1 2.0 0.38 (0.310.48)d 1.1 1.1 1.02 (0.711.48)d
Southwest 42.6 27.3 0.64 (0.610.67)d 22.1 15.4 0.70 (0.660.74)d 23.6 14.9 0.63 (0.590.67)d
B1 157.1 90.1 0.57 (0.540.61)d 61.4 41.9 0.68 (0.620.75)d 108.4 59.0 0.54 (0.510.58)d
14 20.5 16.4 0.80 (0.750.86)d 14.5 10.8 0.75 (0.690.81)d 7.3 7.2 0.99 (0.891.1)
Total 31.9 20.7 0.65 (0.630.67)d 18.3 12.2 0.66 (0.640.69)d 16.0 10.1 0.63 (0.600.66)d
aData from the IHS National Patient Information Reporting System (7).
bRate per 1,000 children of corresponding group.
cRate ratio comparing the 19981999 rate with the 20092011 rate, with 95% CI.































































































Table II. Average annual rates of lower respiratory tract infection (LRTI)-, bronchiolitis- and pneumonia-hospitalizations among the general population of US children aged B5 years,
by age group and sex, 19981999 and 20092011a





















49.3 36.3 0.73 18.7 11.7 0.63 31.8 26.1 0.82
B1
45.553.1 33.139.5 0.650.82d 17.220.1 10.812.7 0.560.70d 29.234.5 23.728.6 0.720.93d
9.1 8.2 0.9 6.8 5.5 0.92 1.9 2.8 1.43
14
8.49.7 7.58.8 0.811.0 6.37.3 5.15.9 0.840.99d 1.82.1 2.53.0 1.241.61d
Sex by age (year)
19.3 15.4 0.80 10.1 7.4 0.73 9.0 8.4 0.92
Male
17.920.7 14.116.6 0.710.88d 9.410.9 6.87.9 0.650.80d 8.39.8 7.69.1 0.811.04
B1
57.0 41.9 0.73 21.3 13.5 0.63 37.0 30.2 0.81
52.661.5 38.245.6 0.650.82d 19.623.0 12.414.6 0.560.70d 33.940.1 27.333.0 0.710.92d
14
10.0 8.8 0.89 7.4 5.8 0.79 2.2 3.0 1.40
9.310.6 8.19.5 0.790.98d 6.97.9 5.46.3 0.710.87d 2.02.3 2.73.3 1.211.58d
14.6 11.9 0.82 8.1 6.0 0.74 6.7 6.3 0.96
Female
13.615.7 10.912.9 0.720.91d 7.58.7 5.56.5 0.660.82d 6.07.1 5.76.9 0.841.08
B1
41.2 30.3 0.74 15.9 9.8 0.62 26.4 21.9 0.83
38.044.3 27.633.1 0.650.82d 14.717.1 9.010.6 0.550.69d 24.228.6 19.824.0 0.720.93d
14
8.1 7.4 0.91 6.2 5.1 0.82 1.7 2.5 1.46
7.58.7 6.88.0 0.811.0 5.76.6 4.75.5 0.730.91d 1.51.8 2.22.7 1.271.66d
17.0 13.7 0.81 9.1 6.7 0.73 7.8 7.4 0.94
Total
15.818.2 12.614.8 0.720.89d 8.59.8 6.27.2 0.660.81d 7.28.5 6.78.0 0.821.06
aData from Nationwide Inpatient Sample (NIS) (8).
bRate per 1,000 children of corresponding group, with 95% CI.
cRate ratio comparing the 19981999 rate with the 20092011 rate, with 95% CI.














































































































much greater in the IHS Alaska and Southwest regions.
Infant pneumonia-associated hospitalization rates in 2
rural Alaska sub-regions were 1015 times the rates for
US infants.
Other studies have reported that AI/AN children have
higher rates of morbidity mortality from pneumonia com-
pared to the general US child population. Groom et al.
(4) reported a mortality rate for pneumonia and influenza
4.8 times higher for AI/AN infants than US white infants
during 19902009. Bronchiectasis secondary to child-
hood pneumonia is a rare lung condition in US children,
but it is commonly diagnosed in AI/AN children living
in Alaska (1420 per 1,000 births) similar to Australian
and New Zealand Indigenous children (18). Pneumonia
with empyema and invasive pneumococcal disease
have also been more common among AI/AN children
(12,19,20).
Various environmental exposures may in part explain
this disparity. Household crowding, indoor smoke, lack
of piped water and poverty have been associated with
LRTIs and are more common in the Alaska and South-
west regions (2124). During the study period, approxi-
mately 27% of households in rural regions of Alaska did
not have access to in-home water service (24). Lack of
access to piped water and having less than 2 sinks in the
home have been shown to be risk factors for LRTIs in
children, factors which could be related to an inability to
perform adequate hand hygiene (24,25). Increasing access
to piped water reduced rates of LRTI-related clinic
encounters in AI/ANs in Alaska (26).
Crowding was more common among AI/AN house-
holds; in the 2000 census, household crowding (1
person per room) occurred in 5.8% of US households
overall compared with 19% of households in US Census-
designated AI/AN, Hawaiian areas (15), and 39% house-
holds in Alaska’s YK Delta sub-region (25). Indoor
smoke from woodstoves and tobacco smoke was com-
mon in AI/AN homes, particularly in the rural Alaska
and Southwest regions (23,25,27,28). In the Southwest
region, presence of a wood stove increased the odds of
LRTI by 4.9 times (27). Passive tobacco smoke exposure
occurred in 4675% of AI/AN households compared to
18% of US households (23,29). Decreasing indoor smoke
from cook stoves reduced physician-diagnosed episodes
of childhood pneumonia in the RESPIRE study in
Guatemala (30).
The decline in pneumonia-associated hospitaliza-
tion rates is likely in part due to the introduction of the
PCV7 in 2000. Griffin et al. (31) estimated that by 2007
2009, the pneumonia-associated hospitalization rate in
US children B2 years fell by 43%. We found similar
reductions of pneumonia hospitalization rates in AI/AN
infants (34%) and children aged 14 years (9.9%) from
19981999 to 20092011; however, our measured reduc-
tion did not specifically quantify the impact of PCV7 on
pneumonia hospitalizations since our analysis included
all listed pneumonia diagnoses, while Griffin et al. (31)
limited pneumonia hospitalizations to the first-listed
discharge diagnosis or pneumonia with a first-listed
diagnosis of meningitis, septicaemia or empyema.
Fig. 1. Average annual hospitalization rates associated with lower respiratory tract infection (LRTI) by disease category (any
pneumonia, bronchiolitis without pneumonia and other LRTI diagnoses) among American Indian/Alaska Native (AI/AN) children
and among the general US child population B5 years of age, by age group, 20092011. Data from the IHS National Patient
Information Reporting System (7) for AI/AN children and the Nationwide Inpatient Sample for the general US child population (8).
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There was a disparity in completion rates of the 4 dose
PCV vaccine between AI/AN and the US non-Hispanic
white child population noted in 2009 (71% vs. 83%,
respectively) and 2011 (75% vs. 85%, respectively); (32,33).
However, the 2010 PCV coverage rate was similar for
AI/AN children compared to the white US population
(32). PCV13 was introduced in March 2010, and coverage
increased to 70% of the US birth cohort by June 2011
(5). In one region of Alaska, 91% of AI/AN children aged
B5 years had received at least one dose of PCV13 by
August 2011 (34). Griffin et al. (35) observed a 27%
decline in pneumonia-associated hospitalizations in
Fig. 2. Annual hospitalization rates associated with lower respiratory tract infection (LRTI), bronchiolitis, pneumonia, respiratory
syncytial virus (RSV) and influenza among American Indian and Alaska Native (AI/AN) children and among the general US child
population B5 years by age group, 19982011. Data from IHS National Patient Information Reporting System (7) for AI/AN children
and the Nationwide Inpatient Sample for the general US child population (8).
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children aged B2 years after introduction of PCV13. We
observed a decrease in AI/AN pneumonia-associated
hospitalizations during 2011 compared to 20092010
(Fig. 2); however, we could not assess the impact of
PCV13 on pneumonia hospitalizations due to limited
time since introduction.
Other factors such as changing hospitalization prac-
tices, improved socioeconomic conditions, community
education and improved household and environmental
factors may have contributed to the decline in pneumo-
nia-associated hospitalization rates in AI/AN children,
before and after introduction of PCV (2,3). Evaluation of
these practices could elucidate the differing trends in rates
among Alaska sub-regions.
The bronchiolitis-associated hospitalization rate in-
creased in US infants from 1980 to 1996, thought to
be due to more medically complex children, increased
oximetry use, increased daycare use and increased RSV
virulence (36,37). In the present study, the bronchiolitis-
associated hospitalization rate for 20092011 decreased
since 19981999 for both AI/AN and the general US
infant population. Another study described a similar de-
crease for US children aged B2 years during 20002009
(38). Possible causes of decreased bronchiolitis-associated
hospitalizations could include a decrease in disease
incidence, differing physician practices regarding hospi-
talization, decrease in passive smoke exposure, differing
child care practices, improved hygiene practices and PCV
(29,38,39).
The AI/AN infants in the Alaska and Southwest
regions had the highest RSV-coded hospitalization rates.
The RSV ICD-9-CM diagnosis coding may vary based on
specimen collection and coding practices; however, during
18 years of RSV surveillance in Alaska’s YK Delta RSV
testing procedures remained stable and RSV-associated
hospitalization was associated with crowding, lack of
piped water, prematurity, and other underlying chronic
medical conditions and lack of breastfeeding (22,24,40).
Exclusive breastfeeding rates remain relatively low in AI/
AN infants through 3 months (40%) and 6 months (12%)
of age, similar to the national average (37% and 17%,
respectively) (41). One study suggested that exclusive
breastfeeding for 4 months decreased the odds of a
doctor-attended LRTI visit by approximately 50% for
children less than 12 months of age (42). During this RSV
surveillance period, improvements in piped water and
decreased household crowding were associated with declines
in RSV- and LRTI-associated hospitalization (43).
During the 20092010 H1N1 influenza pandemic,
AI/AN persons experienced higher morbidity and mor-
tality than the general US population (43,44). In this
analysis, the influenza-associated hospitalization rate was
3 times higher in AI/AN infants than in US infants.
In the Alaska region, the AI/AN infant hospitalization
rate was approximately 12 times greater. Influenza vaccine
coverage remained relatively low in AI/AN children; in
20102011, 67% of AI/AN children aged from 6 months
to 4 years were vaccinated (45). Although the influenza
vaccine coverage rate in AI/AN children was similar to
the US general child population, given the high burden of
influenza in AI/AN children, increasing coverage could
decrease influenza-associated morbidity and mortality
(45,46). One report suggested that requiring influenza
vaccination in child care and pre-school settings increased
vaccination coverage and reduced rates of influenza-
associated hospitalizations in children (46). Administering
the influenza vaccine to pregnant women was also effec-
tive in reducing influenza-associated hospitalizations in
infants in both the general US population and in AI/AN
populations, yet maternal influenza vaccination rates
remain low (4749).
The present study has some limitations. Diagnoses
may be miscoded or incomplete and may vary by hospital
and/or area. Hospital admission criteria, ICD-9-CM
diagnostic coding, and/or pathogen-specific diagnostic
workups for RSV or influenza, and sensitivity or specifi-
city of diagnostic tests may vary between hospitals. The
LRTI trends during the H1N1 influenza pandemic are
not representative of long-term trends (50). No standard
criteria for pneumonia diagnosis are in use nationally, so
pneumonia rate comparisons should be made with caution
(51,52). The IHS data set only includes hospital discharge
data from IHS/tribal and IHS-contract hospitals; records
for AI/AN people hospitalized outside of the IHS health
care system were not included. The NIS data set may
include hospitalizations of AI/AN children who were
hospitalized outside of the IHS/tribal health care system
(6). The population used to calculate the hospitalization
rates for AI/AN children was an estimate of all children
using the IHS/tribal health care system, which may not be
representative of the total AI/AN childhood population.
The number of states reporting to HCUP during 1998
1999 was less than that reporting during 20092011;
however, the NIS from 1993 onward has a large enough
frame to produce reliable national estimates (8).
While LRTI-associated hospitalization rates in AI/AN
children decreased from 19981999 to 20092011, the
rate remained persistently higher in AI/AN children comp-
ared to the general US child population and varied by
IHS region. Analysis of data from laboratory-confirmed
invasive pneumococcal disease, RSV and other respira-
tory viruses in the Alaska and Southwest IHS regions
demonstrate similar trends in these endpoints (12,20,53).
The disparity of LRTI-associated hospitalizations in AI/
AN children is likely multi-factorial and in part related to
increased exposure to indoor smoke, household crowding,
lack of piped water and poverty. Interventions to address
these environmental and socioeconomic factors as well as
Eric M. Foote et al.
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promoting immunization, handwashing and breastfeed-
ing could help in reducing the disparity.
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What is already known on this topic:
1) Lower respiratory tract infections (LRTIs) are the
leading cause of hospitalization in US children.
2) American Indian and Alaska Native children are
more likely to suffer higher rates of morbidity and
mortality due to LRTIs than the general US child
population.
3) The disparity between LRTI-associated hospitaliza-
tions of American Indian and Alaska Native
children and the general US child population has
fallen over time.
What this study adds:
1) American Indian and Alaska Native children ex-
perience higher rates of hospitalization associated
with LRTIs than the general US child population
B5 years of age, while this disparity has declined
over time.
2) The use of the PCV7/PCV13 vaccine is likely
associated with reductions in LRTI-associated hos-
pitalization rates in AI/AN children and the general
US child population.
3) American Indian and Alaska Native infants suffered
higher rates of hospitalization from influenza during
the H1N1 epidemic in 20092010 compared to the
general US infant population.
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